Global Crisis: 10 Pathogens Against Which Antibiotics No Longer Work

Antibiotic resistance has become one of modern medicine's greatest threats. Each year, millions of people worldwide contract bacteria against which conventional drugs have become completely ineffective. Infections that were once easily treated are becoming life-threatening again.

Antibiotic resistance is emerging as one of medicine's most urgent global crises. Bacteria are adapting to drugs at an accelerating pace, rendering once-standard treatments useless and leaving doctors in situations where effective treatment options simply do not exist.

The scale of the crisis globally

Millions of people contract pathogens each year against which conventional antibiotics no longer have any effect. The World Health Organization (WHO) has named antibiotic resistance one of the greatest public health threats, one that in its impact exceeds many other contemporary diseases. Particularly concerning are the so-called superbugs, which have acquired resistance even to the most powerful drugs.

The seriousness of the problem is illustrated by the fact that infections and inflammatory conditions that were successfully treated just decades ago with a simple course of antibiotics are becoming life-threatening once again. These include, for example, certain pneumonia pathogens, urinary tract infection agents, and sepsis pathogens, whose treatment options are steadily narrowing.

The 10 most dangerous resistant pathogens

The WHO has compiled a list of ten priority antibiotic-resistant pathogens against which the development of new drugs is essential. At the top of the list are the gram-negative carbapenem-resistant Acinetobacter baumannii, as well as Pseudomonas aeruginosa and several bacteria of the Enterobacteriaceae family. These microorganisms are particularly dangerous for hospitalised patients and people with weakened immune systems.

The spread of resistant bacteria is closely linked to the overuse of antibiotics in both human medicine and agriculture. Incorrect use of drugs — courses that are too short, wrong dosages, or taking antibiotics against viral infections — accelerates bacterial adaptation and promotes the emergence and spread of resistant strains.

What can be done?

According to experts, solving the crisis requires several parallel steps: developing new antibiotics, promoting the more prudent use of existing drugs, and international cooperation in monitoring and limiting the spread of resistance. In Estonia, the Health Board coordinates work against antibiotic resistance, monitoring the spread of resistant strains in the country and providing guidance to both doctors and patients.